The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2015

Filed:

Dec. 23, 2010
Applicants:

Hana Golding, Rockville, MD (US);

Surender Khurana, Haryana, IN;

Inventors:

Hana Golding, Rockville, MD (US);

Surender Khurana, Haryana, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); G01N 33/569 (2006.01); C07K 14/16 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6854 (2013.01); C07K 14/005 (2013.01); C07K 14/161 (2013.01); C07K 14/162 (2013.01); C07K 14/163 (2013.01); G01N 33/56988 (2013.01); C12N 2740/16111 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16222 (2013.01); C12N 2740/16322 (2013.01); G01N 2333/162 (2013.01); G01N 2469/20 (2013.01);
Abstract

This invention concerns methods for detecting the presence of an anti-HIV-1 antibody in a biological sample, the method comprising conducting an immunoassay comprising: (a) contacting the biological sample with at least one epitope that is recognized by the anti-HIV-1 antibody, wherein the contacting being under conditions sufficient to permit the anti-HIV-1 antibody if present in the sample to bind to the epitope and form an epitope-anti-HIV-1 antibody complex; (b) contacting the formed epitope-anti-HIV-1 antibody complex with an anti-HIV-1 antibody binding molecule, the contacting being under conditions sufficient to permit the anti- HIV-1 antibody binding molecule to bind to anti-HIV-1 antibody of the formed epitope-anti-HIV-1 antibody complex and form an extended complex; and (c) determining the presence or concentration of the anti-HIV-1 antibody in the biological sample by determining the presence or concentration of the formed extended complex; the epitope being present on a peptide comprising SEQ ID No. 55.


Find Patent Forward Citations

Loading…